Skip to content

TO SEE THE EFFICACY OF HOMOEOPATHIC MEDICINE NAME MERCURIUS SOLUBILIS IN CASES OF MOUTH ULCER

EFFICACY OF MERCURIUS SOLUBILIS IN MANAGING BOTH ACUTE AND RECURRENT APHTHOUS ULCERS A CLINICAL ANALYSIS - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098396
Enrollment
30
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K120- Recurrent oral aphthae

Interventions

Intervention1: MERCURIUS SOLUBILIS: 6C/30C/200C/1M OD/BD/TDS THE POTENCY AND REPITITION OF MERCURIUS SOLUBILIS WILL BE SELECTED DEPENDING UPON THE SUSCEPTIBILITY OF PATIENT Control Intervention1: NIL:

Sponsors

DR HENSI AKBARI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ALL AGE GROUPS (CHILDREN, ADULTS, ELDERLY) AND BOTH SEX WITHCLINICALLY DIAGNOSED ACUTE APHTHAE OR RECURRENT APHTHOUS STOMATITIS (RAS). 2.HISTORY OF AT LEAST 2 EPISODES IN THE LAST 6 MONTHS (FOR RECURRENT CASES). 3. WILLINGNESS TO PARTICIPATE AND PROVIDE INFORMED CONSENT (OR PARENTAL CONSENT FOR MINORS).

Exclusion criteria

Exclusion criteria: 1.PATIENTS WITH SYSTEMIC DISEASES CAUSING ORAL ULCERS (E.G., BEH ET S DISEASE, CROHN S DISEASE, CELIAC DISEASE, HIV, LUPUS, TUBERCULOSIS, SYPHILIS, MALIGNANCY). 2.PREGNANT OR LACTATING WOMEN (ETHICAL & SAFETY CONSIDERATION). 3.PATIENTS WITH SEVERE SYSTEMIC ILLNESS (RENAL, HEPATIC, OR CARDIAC FAILURE). 4.PATIENTS CURRENTLY UNDER OTHER ALTERNATIVE INTERVENTIONS FOR APHTHAE.

Design outcomes

Primary

MeasureTime frame
VISUAL ANALOG SCALE (VAS)Timepoint: AT BASELINE AND AT THE END OF TREATMENT AS PER REQUIREMENT OF CASE

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR HENSI AKBARI

BARODA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

dr.jaykumarchandarana@gmail.com9824475588

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026